97 related articles for article (PubMed ID: 3493314)
1. Cimetidine modulates natural killer cell function of patients with chronic lymphocytic leukemia.
Allen JI; Syropoulos HJ; Grant B; Eagon JC; Kay NE
J Lab Clin Med; 1987 Apr; 109(4):396-401. PubMed ID: 3493314
[TBL] [Abstract][Full Text] [Related]
2. Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia.
Foa R; Lauria F; Lusso P; Giubellino MC; Fierro MT; Ferrando ML; Raspadori D; Matera L
Br J Haematol; 1984 Nov; 58(3):509-16. PubMed ID: 6333890
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia.
Ziegler HW; Kay NE; Zarling JM
Int J Cancer; 1981 Mar; 27(3):321-7. PubMed ID: 6169660
[TBL] [Abstract][Full Text] [Related]
4. Restoration of impaired natural killer cell activity of B-chronic lymphocytic leukemia patients by recombinant interleukin-2.
Kay NE; Zarling J
Am J Hematol; 1987 Feb; 24(2):161-7. PubMed ID: 3028132
[TBL] [Abstract][Full Text] [Related]
5. [Regulation of the natural killer activity of lymphocytes from healthy donors and patients with chronic lympholeukemia through the interaction of T- and non-T cells].
Khonina NA; Shubinskiĭ GZ; Lozovoĭ VP
Biull Eksp Biol Med; 1987 Mar; 103(3):321-3. PubMed ID: 3493815
[TBL] [Abstract][Full Text] [Related]
6. Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cells.
Pattengale PK; Gidlund M; Nilsson K; Sundström C; Sällström J; Simonsson B; Wigzell H
Int J Cancer; 1982 Jan; 29(1):1-7. PubMed ID: 6174459
[TBL] [Abstract][Full Text] [Related]
7. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
[TBL] [Abstract][Full Text] [Related]
8. Expression of NK-lineage markers on peripheral blood lymphocytes with T-helper (Leu3+/T4+) phenotype in B cell chronic lymphocytic leukemia.
Velardi A; Prchal JT; Prasthofer EF; Grossi CE
Blood; 1985 Jan; 65(1):149-55. PubMed ID: 3155487
[TBL] [Abstract][Full Text] [Related]
9. Clinical signification of natural killer activity in B-cell chronic lymphocytic leukemia.
Alvarez-Mon M; Casas J; Laguna R; Jordá J; Durantez A
Eur J Haematol; 1987 Mar; 38(3):268-73. PubMed ID: 3496239
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabine.
Robertson LE; Denny AW; Huh YO; Plunkett W; Keating MJ; Nelson JA
Cancer Chemother Pharmacol; 1996; 37(5):445-50. PubMed ID: 8599867
[TBL] [Abstract][Full Text] [Related]
11. Effect of histamine and histamine antagonists on natural and antibody-dependent cellular cytotoxicity of human lymphocytes in vitro.
Nair MP; Schwartz SA
Cell Immunol; 1983 Oct; 81(1):45-60. PubMed ID: 6225527
[TBL] [Abstract][Full Text] [Related]
12. The effect of cimetidine on natural killer activity of peripheral blood lymphocytes of patients with ovarian carcinoma.
Kikuchi Y; Oomori K; Kizawa I; Kato K
Jpn J Clin Oncol; 1985 Jun; 15(2):377-83. PubMed ID: 3839542
[TBL] [Abstract][Full Text] [Related]
13. [The effect of cimetidine mainly increases CD4+ cells of peripheral blood T lymphocytes].
Asakage M; Tsuno NH; Kitayama J; Yamada J; Tsuchiya T; Yoneyama S; Takahashi K; Nagawa H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1576-7. PubMed ID: 16315874
[TBL] [Abstract][Full Text] [Related]
14. Unmasking of cryptic natural killer (NK) cell recognition sites on chronic lymphocytic leukemia lymphocytes.
Spitz DL; Zucker-Franklin D; Nabi ZF
Am J Hematol; 1988 Jul; 28(3):155-61. PubMed ID: 3136646
[TBL] [Abstract][Full Text] [Related]
15. Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial.
Lin CY; Bai DJ; Yuan HY; Wang K; Yang GL; Hu MB; Wu ZQ; Li Y
World J Gastroenterol; 2004 Jan; 10(1):136-42. PubMed ID: 14695785
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
Sharma B; Vaziri ND
Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
[TBL] [Abstract][Full Text] [Related]
17. Generation of non-MHC restricted killing in cultures stimulated with B cells from chronic lymphocytic leukaemia patients: phenotypic characterization of the precursor and effector cells.
Matera L; Foa R; Malavasi F; Bellone G; Funaro A; Veglia F; Santoli D
Clin Exp Immunol; 1988 May; 72(2):303-8. PubMed ID: 3261664
[TBL] [Abstract][Full Text] [Related]
18. Patients with a deficiency of natural killer cell activity lack the VEP13-positive lymphocyte subpopulation.
Ziegler-Heitbrock HW; Rumpold H; Kraft D; Wagenpfeil C; Munker R; Abo T; Balch CM; LeBien TW
Blood; 1985 Jan; 65(1):65-70. PubMed ID: 3965053
[TBL] [Abstract][Full Text] [Related]
19. [Natural killer cells lysing the blood B-lymphocytes of patients with chronic lympholeukemia].
Khonina NA; Shubinskiĭ GZ
Eksp Onkol; 1988; 10(4):44-6. PubMed ID: 3263265
[TBL] [Abstract][Full Text] [Related]
20. Effects of cimetidine on various biological activities of human leucocyte interferon and on interferon production in lymphocytes.
Hirai N; Hattori N; Hill NO; Osther K
Tohoku J Exp Med; 1985 Oct; 147(2):199-212. PubMed ID: 2934865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
